99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 131-138

  Biassoni, L ^a   Granowska, M ^a   Carroll, M J ^a   Mather, S J ^a   Howell, R ^a   Ellison, D ^a   MacNeill, F A ^a   Wells, C A ^a   Carpenter, R ^a   Britton, K E ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Axillary lymph node; Breast cancer; Change detection analysis; Monoclonal antibody; Radioimmunoscintigraphy:

Indexed keywords

TECHNETIUM 99M; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; TECHNETIUM;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SCINTISCANNING; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOSCINTIGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; AXILLA; BREAST TUMOR; DRUG EFFECT; IMAGE PROCESSING; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PILOT STUDY; RADIOIMMUNOASSAY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; THORAX;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; MIDDLE AGED; MODELS, STATISTICAL; PILOT PROJECTS; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY; TECHNETIUM; THORAX;

EID: 0031594154     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.21     Document Type: Article

References (32)

1. Adler LP, Crowe JP, Al-Kaisai NK and Sunshine JL (1993) Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 187: 743-750
2. Avril N, Janicke F, Dose J, Ziegler S, Bense S, Zincke M, Romer W, Weber W, Herz M and Schwaiger M (1995) Evaluation of axillary lymph node involvement in breast cancer patients using F-18 FDG PET. Eur J Nucl Med 22: 733
3. Biersack HJ (1995) Mammoscintipraphy with Tc-99m MIB1 in patients with suspicious breast nodules: a comparison of planar and SPECT imaging techniques. Eur J Nucl Med 22: 725
4. Bischof-Delaloye A, Delaloye B, Buchegger F, Gilgien W, Studer A, Curchod S, Givel JC, Mosimann F, Pettavil J and Mach J-P (1989) Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective trial. J Nucl Med 30: 1646-1656
5. Britton KE and Granowska M (1987) Radioimniunoscintigraphy in tumour identification. Cancer Surg 6: 1247-1267
6. Britton KE and Granowska M (1993) The present and the future of radiolabelled antibodies in oncology. Ann Nucl Med 7: 127-132
7. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R and Lamport D (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47: 5476-5482
8. Burchell J and Taylor-Papadimitriou J (1993) Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epith Cell Biol 2: 155-162
9. Deckers PJ (1991) Axillary dissection in breast cancer: when, why, how much, and for how long? Are these operations soon to be extinct? J Surg Oncol 48: 217-219
10. Deland FH, Kim BE, Corgan RL, Casper FS, Primus FJ, Spremulli E, Estes N and Goldenberg DM (1979) Axillary lymphoscintigraphy by radioimmunodetection of carcino-embryonic antigen in breast cancer. J Nucl Med 20: 1243-1250
11. Doerr RJ, Abdel-Nabi H, Baker JM and Steinberg S (1990) Detection of primary colorectal cancer using indium-111 monoclonal antibody B72.3. Arch Surg 125: 1601-1605
12. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montegue E, Margolese R and Foster R (1985) Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681
13. Girling A, Bartkova J, Burchell J, Gendler S, Gillet C and Taylor-Papadimitriou J (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43: 1072-1076
14. Goldenberg DM and Larson SM (1992) Radioimmunodetection in cancer identification. J Nucl Med 33: 803-814
15. Granowska M, Nimmon CC, Britton KE, Crowther M, Mather SJ, Slevin ML and Shepherd JH (1988) Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy. J Nucl Med 29: 599-607
16. Granowska M, Jass JR, Britton KE and Northover JMA (1989) A prospective study of the use of 111 In-labelled monoclonal antibody against carcinoembryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorect Dis 4: 97-108
17. Granowska M, Mather SJ, Jobling T, Naeem M, Birchall J, Taylor Papadimitriou J, Shepherd J and Britton KE (1990) Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Int J Biol Mark 5: 89-96
18. Granowska M, Britton KE, Mather SJ, Lowe DG, Ellison D, Bomanji J, Birchall J, Taylor Papadimitriou J, Hudson CR and Shepherd JH (1993) Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, SM3, in gynaecological cancer. Eur J Nucl Med 20: 483-488
19. 99mTc SM3 Radioimmunoscintigraphy. Acta Oncol 35: 319-321
20. Harris JR and Osteen RT (1985) Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5: 17-21
21. Khalkhali I, Mena I, Jouanne E, Diggles L, Venegas R, Block J, Alle K and Klein S (1994) Prone scintimammography in patients with suspicion of breast cancer. J Am Coll Surg 178: 491-197
22. Krag DN, Weaver DL, Alex JC and Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335-340
23. McEwan AJB, Akram I, Boniface G, Golberg L, McQuarrie SA, Golberg K, Amyotte G, Hornig B, Noujaim AA and MacLean GD (1994) Tc-99m monoclonal antibody in the evaluation of locoregional disease in patients with breast cancer. Eur J Nucl Med 21 (suppl.): S15
24. Massuger LFAG, Keenemans P, Claessens RAMJ et al (1990) Immunoscintigraphy of ovarian cancer using indium-111 labelled OV-TL3 F(ab′)2 monoclonal antibody. J Nucl Med 31: 1802-1810
25. Mather SJ and Ellison D (1990) Reduction-mediated Tc-99m labelling of monoclonal antibodies. J Nucl Med 31: 692-697
26. Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE and Tilbury RS (1993) Positron Emission Tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 71: 3920-3925
27. Palmedo H, Grunwald F, Bender H, Schomburg A, Mallmann P, Krebs B and Biersack HJ (1996) Scintimammography with Technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 23: 940-946
28. Silverstein MJ, Giersone D, Waisman JR, Senofsky GM, Colburn WJ and Gamagami P (1994) Axillary lymph node dissection for T1a breast carcinoma - Is it indicated? Cancer 73: 664-667
29. Schatten C, Bawada M, Mandeville R, Enzelsberger H, Angelberger P, Czerwenka K, Kubista E and Pateisky N (1994) Combined use of 123-I labelled BCDF9 and 4C4 monoclonal antibodies with dissimilar specificity for breast cancer: implication for detection limits of immunolymphoscintigraphy in the assessment of axillary lymph nodes. Nucl Med Comm 15: 422-429
30. Tjandra JJ, Russell IS, Collins JP, Andrews JT, Lichtenstein M, Binns D and McKenzie IFC (1989) Immunolymphoscintigraphy for the detection of lymph node metastases from breast carcinoma. Cancer Res 49: 1600-1608
31. Wahl RL, Cody RL, Hutchins GD and Mudgett EE (1991) Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabelled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179: 765-770
32. Wahl R (1992) Monoclonal antibodies in nuclear medicine. In Nuclear Medicine Annual 1992, Freeman L (ed.), Raven Press: New York